Specifications include, but are not limited to: The main tasks associated with the grant are as follows: 7.1 Distributing Naloxone Statewide The Grant Recipient shall perform statewide naloxone distribution. The products shall be reimbursed at a set price reimbursement or actual cost of the product, whichever is lower, and is preferred to not be obtained by a named party in ongoing opioid abatement settlement litigation in the state of Texas. The products will be distributed at zero cost to the recipient. The distribution of funds for purposes of purchasing and distributing naloxone products shall be allocated as outlined in Section 9.0. Eligible products for distribution must be approved overdose reversal medications by the federal Food and Drug Administration, which may include: • Injectable brands of naloxone; • Prepackaged nasal spray brands of naloxone; and • Prepackaged nasal spray kit of naloxone.